A carregar...
Combination of Linagliptin and Empagliflozin Preserves Cardiac Systolic Function in an Ischemia-Reperfusion Injury Mice With Diabetes Mellitus
BACKGROUND: Sodium-glucose co-transporter 2 inhibitor (SGLT2i) and dipeptidyl peptidase 4 inhibitor (DPP4i) are oral hypoglycemic agents. Although SGLT2i has been shown having the beneficial effects on heart failure in basic and clinical studies, the combined effects of SGLT2i and DPP4i have not bee...
Na minha lista:
| Publicado no: | Cardiol Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7935637/ https://ncbi.nlm.nih.gov/pubmed/33738012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr1194 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|